Clinicopathological Characteristics of Early-Onset Prostate Cancer in Black African Men: A Single-Centre Cohort from Johannesburg

Abstract Purpose Early-onset prostate cancer (EOPC) is poorly characterised in African populations. We describe the clinicopathological features of men aged ≤ 55 years diagnosed with prostate cancer at a Johannesburg public-sector hospital. Methods We retrospectively analysed men aged ≤ 55 years with histologically confirmed prostate adenocarcinoma enrolled at the Chris Hani Baragwanath Academic Hospital site of the Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium between October 2016 and August 2020. High-risk or advanced disease and clinically significant disease were study-defined composites adapted from EAU risk groups. Exploratory logistic regression assessed associated factors. Results Seventy-seven of 1,095 men (7.0%) were aged ≤ 55 years; median age was 53 years. High-risk or advanced disease was present in 38 men (49.4%) and clinically significant disease in 56 (72.7%). Initial PSA exceeded 20 ng/mL in 35 men (45.5%), 23 (29.9%) had ISUP Grade Group 4–5 disease, and distant metastases were documented in 8 of the 69 men with an assessable M stage (11.6%). Median initial PSA was 17.8 ng/mL. Prior prostatitis or inflammation was recorded in 63 men (81.8%), and 53 (68.8%) had been treated for urinary symptoms before the cancer diagnosis. Abnormal digital rectal examination was associated with both study endpoints after adjustment, although confidence intervals were wide. Conclusion Early-onset disease accounted for 7.0% of prostate cancers at this centre; half met criteria for high-risk or advanced disease and almost three-quarters for clinically significant disease. The frequency of prior prostatitis diagnoses and urinary treatment highlights the need to better understand diagnostic pathways in younger men.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11565655/v1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Clinicopathological Characteristics of Early-Onset Prostate Cancer in Black African Men: A Single-Centre Cohort from Johannesburg

Shingai Bertrand Angelo Mutambirwa, Wenlong Carl Chen, Sean Doherty, Ahmed Adam et al.
Research Square
Prostate Cancer Diagnosis and Treatment
preprint

Clinicopathological Characteristics of Early-Onset Prostate Cancer in Black African Men: A Single-Centre Cohort from Johannesburg

Shingai Bertrand Angelo Mutambirwa, Wenlong Carl Chen, Sean Doherty, Ahmed Adam, Timothy Richard Rebbeck, Akram Bokhari, Eesaa Cassim Docrat, Ekene Emmanuel Nweke
preprint en

Abstract

Abstract Purpose Early-onset prostate cancer (EOPC) is poorly characterised in African populations. We describe the clinicopathological features of men aged ≤ 55 years diagnosed with prostate cancer at a Johannesburg public-sector hospital. Methods We retrospectively analysed men aged ≤ 55 years with histologically confirmed prostate adenocarcinoma enrolled at the Chris Hani Baragwanath Academic Hospital site of the Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium between October 2016 and August 2020. High-risk or advanced disease and clinically significant disease were study-defined composites adapted from EAU risk groups. Exploratory logistic regression assessed associated factors. Results Seventy-seven of 1,095 men (7.0%) were aged ≤ 55 years; median age was 53 years. High-risk or advanced disease was present in 38 men (49.4%) and clinically significant disease in 56 (72.7%). Initial PSA exceeded 20 ng/mL in 35 men (45.5%), 23 (29.9%) had ISUP Grade Group 4–5 disease, and distant metastases were documented in 8 of the 69 men with an assessable M stage (11.6%). Median initial PSA was 17.8 ng/mL. Prior prostatitis or inflammation was recorded in 63 men (81.8%), and 53 (68.8%) had been treated for urinary symptoms before the cancer diagnosis. Abnormal digital rectal examination was associated with both study endpoints after adjustment, although confidence intervals were wide. Conclusion Early-onset disease accounted for 7.0% of prostate cancers at this centre; half met criteria for high-risk or advanced disease and almost three-quarters for clinically significant disease. The frequency of prior prostatitis diagnoses and urinary treatment highlights the need to better understand diagnostic pathways in younger men.

Research Square
Harvard University (US), University of the Witwatersrand (ZA), Sefako Makgatho Health Sciences University (ZA), University of Ha'il (SA), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US)
Wellcome Trust, European Commission, Foreign, Commonwealth and Development Office, National Cancer Institute
Good health and well-being
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon